Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res. 2010; 12(6):R102.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Breast Neoplasms
Female
Gene Expression
Genes, BRCA2
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Linkage Disequilibrium
Middle Aged
Mutation
Polymorphism, Single Nucleotide
Risk Factors
Signal Transduction
Smad3 Protein
Transforming Growth Factor beta
authors with profiles
Timothy R Rebbeck, Ph.D.